D
Blueprint Medicines Corporation BPMC
$87.11 -$2.90-3.22%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 11.23% -12.56% -156.09% 180.36% 17.05%
Total Depreciation and Amortization 3.57% 6.80% -24.80% 214.17% -46.69%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 14.67% -7.18% 116.49% -859.27% -14.26%
Change in Net Operating Assets -165.56% 157.68% 37.95% -515.25% 250.07%
Cash from Operations -115.33% 71.63% 52.64% -28.61% 24.46%
Capital Expenditure -3,628.00% 99.03% -132.70% 76.37% 25.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 15.56% 116.14% -337.39% -6.24% 2,602.01%
Cash from Investing 12.55% 115.91% -344.12% -2.08% 921.71%
Total Debt Issued -- -100.00% -- -- -100.04%
Total Debt Repaid -- 100.00% 53.39% -738.64% --
Issuance of Common Stock -46.90% -41.12% -53.65% 331.42% 3,521.11%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -46.90% -89.68% 165.84% 331.24% -84.22%
Foreign Exchange rate Adjustments -324.03% 2,006.45% 78.62% -129.77% 190.02%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -63.78% 160.43% -237.58% 167.63% 197.81%
Weiss Ratings